Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Researchers develop CFTR-mutated cystic fibrosis murine model to allow gene-editing strategies

Nov. 11, 2021

New cystic fibrosis mouse models allow testing of therapies for W1282X nonsense mutations

Nov. 10, 2021

CG-223 demonstrates antifibrotic effects in a murine model of pulmonary fibrosis

Nov. 9, 2021

Virulent factors of P. aeruginosa isolates are upregulated under anaerobic conditions

Nov. 9, 2021

Analysis of lung phenotype in rat CF models using flexiVent and X-ray velocimetry

Nov. 8, 2021

New JAK inhibitors patented by Gossamer Bio

Nov. 8, 2021

Researchers develop a cystic fibrosis-related diabetes murine model

Nov. 8, 2021

F508del and G542X cystic fibrosis sheep models exhibit severe phenotype

Nov. 5, 2021

BPN-15477 corrects splicing defect caused by the c.2988G>A variant in CFTR

Nov. 5, 2021

ELD-607 reduces pulmonary inflammation and lung damage in vivo

Nov. 5, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...